Physician profile
Michael Gitter
NPI 1487712865
$852.36
in general payments reported to CMS, 2019-2025
14 companies · $73.79 in 2025
The $73.79 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $66.27 · 2021: $55.65 · 2022: $50.78 · 2023: $256 · 2024: $53.28 · 2025: $73.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $225.11 | 2020-2025 | Mounjaro, Zepbound |
| Merz North America, INC. | $126.74 | 2023 | Xeomin |
| Galderma Laboratories, L.P. | $112.99 | 2019-2020 | |
| Allergan, INC. | $73.69 | 2020-2022 | |
| Abbvie INC. | $70.40 | 2019-2023 | |
| New Horizon Medical Solutions | $47.01 | 2025 | |
| Novo Nordisk INC | $40.71 | 2019 | |
| Astellas Pharma US INC | $38.76 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.49 | 2019 | |
| Merck Sharp & Dohme LLC | $23.04 | 2021 | |
| Boston Scientific Corporation | $18.96 | 2024 | Wavewriter Alpha Prime 16 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.83 | 2019 | |
| Glaxosmithkline, LLC. | $13.04 | 2019 | |
| Mdd US Operations, LLC | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gitter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.